While the clinical evidence for microdosing GLP-1 medications is still emerging, some users report that it helps them manage side effects while using medication more efficiently
Fish and shellfish NHS
Diabetes, cardiovascular disease, and obesity are independent risk factors for kidney disease and represent a major global health burden
The GH/IGF-1 axis promotes muscle protein synthesis and lean body mass gain, enhances lipolysis and fat oxidation (reducing adipose tissue), stimulates bone formation and mineralization, supports immune function, influences cognitive function and mood, improves sleep quality and architecture, enhances skin collagen production and thickness, and modulates glucose and lipid metabolism
Still, future research might offer more clarity
Tarazona, A., Rodrguez, J., Restrepo, L